Viet Nam Medicinal Materials JSC
VN:DVM
Balance Sheet
Balance Sheet Decomposition
Viet Nam Medicinal Materials JSC
Viet Nam Medicinal Materials JSC
Balance Sheet
Viet Nam Medicinal Materials JSC
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
24 308
|
89 871
|
127 603
|
104 848
|
85 716
|
|
| Cash |
9 308
|
25 379
|
56 433
|
48 482
|
50 050
|
|
| Cash Equivalents |
15 000
|
64 492
|
71 169
|
56 366
|
35 667
|
|
| Short-Term Investments |
0
|
0
|
29 700
|
94 773
|
118 907
|
|
| Total Receivables |
293 236
|
307 748
|
314 784
|
320 643
|
440 598
|
|
| Accounts Receivables |
261 296
|
263 287
|
288 329
|
316 097
|
431 952
|
|
| Other Receivables |
31 940
|
44 460
|
26 455
|
4 546
|
8 645
|
|
| Inventory |
211 260
|
250 559
|
289 465
|
230 959
|
238 256
|
|
| Other Current Assets |
91 638
|
59 725
|
70 423
|
71 874
|
58 776
|
|
| Total Current Assets |
620 443
|
707 903
|
831 975
|
823 097
|
942 253
|
|
| PP&E Net |
126 427
|
253 541
|
378 245
|
443 763
|
370 677
|
|
| PP&E Gross |
126 427
|
253 541
|
378 245
|
443 763
|
370 677
|
|
| Accumulated Depreciation |
23 325
|
33 192
|
41 014
|
65 315
|
90 347
|
|
| Intangible Assets |
41 302
|
56 481
|
142 094
|
157 856
|
206 991
|
|
| Note Receivable |
27 974
|
10 601
|
3 481
|
85 559
|
93 580
|
|
| Long-Term Investments |
0
|
0
|
0
|
20 000
|
20 000
|
|
| Other Long-Term Assets |
4 709
|
4 417
|
3 470
|
2 645
|
1 069
|
|
| Total Assets |
820 855
N/A
|
1 032 943
+26%
|
1 359 266
+32%
|
1 532 921
+13%
|
1 634 570
+7%
|
|
| Liabilities | ||||||
| Accounts Payable |
106 669
|
54 764
|
55 075
|
94 165
|
92 564
|
|
| Accrued Liabilities |
6 336
|
8 504
|
9 645
|
8 893
|
7 732
|
|
| Short-Term Debt |
334 053
|
355 109
|
549 939
|
658 204
|
723 090
|
|
| Current Portion of Long-Term Debt |
14 045
|
28 568
|
21 038
|
21 274
|
17 576
|
|
| Other Current Liabilities |
14 010
|
3 622
|
18 377
|
16 609
|
28 825
|
|
| Total Current Liabilities |
475 113
|
450 568
|
654 073
|
799 144
|
869 787
|
|
| Long-Term Debt |
122 588
|
140 150
|
54 997
|
42 481
|
25 886
|
|
| Other Liabilities |
11 597
|
1 603
|
1 966
|
2 623
|
2 349
|
|
| Total Liabilities |
609 298
N/A
|
592 321
-3%
|
711 035
+20%
|
844 248
+19%
|
898 023
+6%
|
|
| Equity | ||||||
| Common Stock |
150 000
|
270 000
|
356 500
|
356 500
|
427 799
|
|
| Retained Earnings |
31 558
|
78 470
|
125 364
|
160 364
|
104 867
|
|
| Additional Paid In Capital |
30 000
|
90 000
|
159 200
|
159 200
|
159 200
|
|
| Other Equity |
0
|
2 152
|
7 166
|
12 608
|
44 681
|
|
| Total Equity |
211 558
N/A
|
440 622
+108%
|
648 231
+47%
|
688 672
+6%
|
736 547
+7%
|
|
| Total Liabilities & Equity |
820 855
N/A
|
1 032 943
+26%
|
1 359 266
+32%
|
1 532 921
+13%
|
1 634 570
+7%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
15
|
32
|
47
|
47
|
47
|
|